Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Funko
FNKO
$326M
| $3.5M | ﹤0.01% |
164,220
+9,840
| +6% | +$224K |
|
2527
First Financial Corp
THFF
$958M
| $3.49M | ﹤0.01% |
85,397
-1,144
| -1% | -$50.8K |
|
|
STEL
2528
DELISTED
Stellar Bancorp
STEL
| $3.48M | ﹤0.01% |
127,531
+2,759
| +2% | +$83K |
|
|
EGRX
2529
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.45M | ﹤0.01% |
80,656
+3,653
| +5% | +$151K |
|
|
AKRO
2530
DELISTED
Akero Therapeutics
AKRO
| $3.45M | ﹤0.01% |
138,993
+27,882
| +25% | +$783K |
|
2531
Nurix Therapeutics
NRIX
$2.41B
| $3.45M | ﹤0.01% |
129,888
+16,953
| +15% | +$498K |
|
|
DHIL
2532
DELISTED
Diamond Hill
DHIL
| $3.44M | ﹤0.01% |
20,581
+220
| +1% | +$37.7K |
|
2533
DHT Holdings
DHT
$2.99B
| $3.44M | ﹤0.01% |
529,801
-39,753
| -7% | -$244K |
|
2534
Hims & Hers Health
HIMS
$6.43B
| $3.44M | ﹤0.01% |
315,446
+7,847
| +3% | +$93.3K |
|
|
GNOG
2535
DELISTED
Golden Nugget Online Gaming, Inc. Class A Common Stock
GNOG
| $3.43M | ﹤0.01% |
268,483
+114,865
| +75% | +$1.56M |
|
2536
Lindblad Expeditions
LIND
$1.94B
| $3.42M | ﹤0.01% |
213,909
+16,521
| +8% | +$279K |
|
2537
Rayonier Advanced Materials
RYAM
$604M
| $3.42M | ﹤0.01% |
511,251
+82,338
| +19% | +$671K |
|
2538
Alpha and Omega Semiconductor
AOSL
$950M
| $3.42M | ﹤0.01% |
112,406
+59,703
| +113% | +$1.83M |
|
2539
Nkarta
NKTX
$150M
| $3.41M | ﹤0.01% |
107,615
-11,482
| -10% | -$331K |
|
2540
American Outdoor Brands
AOUT
$155M
| $3.4M | ﹤0.01% |
96,794
+3,656
| +4% | +$108K |
|
|
LORL
2541
DELISTED
Loral Space and Communications, Inc.
LORL
| $3.4M | ﹤0.01% |
87,414
-51
| -0.1% | -$1.94K |
|
2542
First Community Bankshares
FCBC
$900M
| $3.39M | ﹤0.01% |
113,640
+1,791
| +2% | +$54.1K |
|
2543
Babcock & Wilcox
BW
$1.39B
| $3.39M | ﹤0.01% |
429,820
+131,542
| +44% | +$1.09M |
|
2544
Tidewater
TDW
$3.73B
| $3.38M | ﹤0.01% |
280,896
+5,071
| +2% | +$67.4K |
|
|
PLYA
2545
DELISTED
Playa Hotels & Resorts
PLYA
| $3.38M | ﹤0.01% |
454,902
+16,459
| +4% | +$121K |
|
2546
IMAX
IMAX
$2.62B
| $3.35M | ﹤0.01% |
156,025
+28,747
| +23% | +$619K |
|
2547
Shattuck Labs
STTK
$675M
| $3.35M | ﹤0.01% |
115,609
+28,387
| +33% | +$830K |
|
2548
BioAtla
BCAB
$5.46M
| $3.35M | ﹤0.01% |
1,580
+54
| +4% | +$122K |
|
2549
American Vanguard Corp
AVD
$68.4M
| $3.34M | ﹤0.01% |
190,971
+4,881
| +3% | +$92.7K |
|
2550
Keros Therapeutics
KROS
$199M
| $3.34M | ﹤0.01% |
78,584
+20,274
| +35% | +$1.1M |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.